ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels

(2019) Aline S.C. Fabricio et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

(2016) Severine Iborra et al.   Breast Care

Biotin-Streptavidin Competition Mediates Sensitive Detection of Biomolecules in Enzyme Linked Immunosorbent Assay

(2016) Thangavel Lakshmipriya et al.   PLoS One

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015

(2015) Dimitrios Zardavas et al.   BREAST

A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis

(2015) Kin-Mei Leung et al.   MOLECULAR THERAPY

Editorial: Antibody Can Get It Right: Confronting Problems of Antibody Specificity and Irreproducibility

(2014) Agnes Schonbrunn   MOLECULAR ENDOCRINOLOGY

Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore

(2013) Eric S. Day et al.   ANALYTICAL BIOCHEMISTRY

Multiplexed Electrochemical Protein Detection and Translation to Personalized Cancer Diagnostics

(2013) James F. Rusling   ANALYTICAL CHEMISTRY

Finding the right antibody for the job

(2013) Vivien Marx   NATURE METHODS

Optimisation and standardisation of an immunoagglutination assay for the diagnosis ofTrypanosoma cruziinfection based on latex-(recombinant antigen) complexes

(2013) Valeria S. Garcia et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Comparative Binding of Disulfide-Bridged PEG-Fabs

(2012) Hanieh Khalili et al.   BIOCONJUGATE CHEMISTRY

Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology

(2012) Jianxia Wang et al.   Future Oncology

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

(2011) Ningyan Zhang et al.   mAbs

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value

(2010) Rafael Molina et al.   TUMOR BIOLOGY

Effectiveness of natural and synthetic blocking reagents and their application for detecting food allergens in enzyme-linked immunosorbent assays

(2009) Denise Huber et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2 ) with antibodies

(2009) Johan Rockberg et al.   Molecular Oncology

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

(2008) C. M. Sturgeon et al.   CLINICAL CHEMISTRY

Differential binding of human immunoagents and Herceptin to the ErbB2 receptor

(2008) Fulvia Troise et al.   FEBS Journal